Chemical Structure (Image 01)
Chemical structure of lisdexamfetamine dimesylate, showing the molecular arrangement of the active ingredient components.*
Lisdexamfetamine Dimesylate Capsule
Product Images NDC 43547-605
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Lisdexamfetamine Dimesylate (NDC 43547-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Solco Healthcare Us,llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Image 02)
A pharmacokinetic fold change chart showing Cmax and AUC values with 90% confidence intervals for lisdexamfetamine dimesylate across special populations including gender, age groups 65-74 and 75+, and renal impairment levels from mild to end-stage renal disease. The x-axis represents change relative to reference from 0.0 to 2.5.*
Figure 2 (Image 03)
A pharmacokinetic chart illustrating fold change and 90% confidence intervals for Cmax and AUC parameters of three drugs—Guanfacine, Venlafaxine, and Omeprazole—showing change relative to a reference on the x-axis ranging from 0.0 to 2.0.*
Figure 3 (Image 04)
A pharmacokinetic chart showing fold changes with 90% confidence intervals for various interacting drugs including Guanfacine, Venlafaxine, Caffeine, Dextromethorphan, Omeprazole, and Midazolam. The chart compares Cmax and AUC values relative to a reference, indicating changes in drug levels.*
Figure 4 (Image 05)
Line graph comparing LS Mean (SE) SKAMP Deportment Scores over time post-dose in hours for Lisdexamfetamine dimesylate capsules versus placebo. The x-axis represents time from 0 to 13 hours, and the y-axis shows scores from 0 to 2. The graph includes lines with error bars for both treatment groups, illustrating changes in scores over time.*
Figure5 (Image 06)
A Kaplan-Meier survival curve comparing proportion of subjects with relapse or treatment failure over time (in days) after randomization between SPD489 (solid line) and placebo (dashed line). The graph shows lower relapse rates for SPD489 compared to placebo across approximately 50 days.*
Figure 6 (Image 07)
A line graph comparing LS Mean (SE) PERMP Total Scores over Time Post-Dose (hours) between placebo and lisdexamfetamine dimesylate capsules. The graph shows scores on the vertical axis from 250 to 330, and time ranging from -0.5 to 14 hours. Lisdexamfetamine dimesylate capsules trend higher than placebo throughout the measured times, with error bars shown for variability.*
Figure7 (Image 08)
A line chart comparing the proportion of subjects with relapse or treatment failure (%) over time (days after randomization) for lisdexamfetamine dimesylate capsules versus placebo. The graph shows lower relapse rates in the lisdexamfetamine group with a steady proportion below 10%, compared to higher and increasing rates for placebo reaching about 75% by day 35.*
Figure 8 (Image 09)
A line graph depicting the proportion of subjects with relapse over time in days after randomization, comparing Lisdexamfetamine dimesylate capsules to placebo. The x-axis represents time in days, and the y-axis shows the percentage of subjects with relapse. The graph includes lines for Lisdexamfetamine dimesylate capsules and placebo, with a decreasing number of subjects at risk shown below the x-axis.*
10 (Image 10)
Label for Lisdexamfetamine dimesylate capsules 10 mg by Solco Healthcare US, LLC. The label includes dosage strength 10 mg, contains 100 capsules, and indicates prescription use (Rx only). It displays storage instructions, manufacturer (Prinston Laboratories), distributor details, a barcode, and a note to see package insert for dosage information.*
20 (Image 11)
Packaging label for Lisdexamfetamine dimesylate capsules, 20 mg strength. The label indicates the prescription-only status and contains a note for pharmacists to dispense the medication guide. It also details the package contains 100 capsules and provides manufacturer and distributor information for Solco Healthcare US, LLC.*
40 (Image 12)
Lisdexamfetamine dimesylate capsules 30 mg label from Solco Healthcare US, LLC. The label includes dosage strength, prescription use indication, storage instructions, manufacturer and distributor information, a barcode, and a note directing pharmacists to dispense the Medication Guide separately. The package size is indicated as 100 capsules.*
40 (Image 13)
Lisdexamfetamine dimesylate capsules 40 mg oral capsules label from Solco Healthcare US, LLC. The label includes dosage strength, quantity of 100 capsules, NDC 43547-605-10, and instructions for pharmacists to dispense the medication guide separately. Storage instructions and manufacturer information are also provided.*
50 (Image 14)
Label for Lisdexamfetamine dimesylate capsules 50 mg by Solco Healthcare US, LLC. The label advises storage at controlled room temperature and includes the NDC 43547-606-10. It contains 100 capsules and instructs pharmacists to dispense the Medication Guide separately. Manufactured by Prinston Laboratories, Charlotte, NC.*
60 (Image 15)
Label for Lisdexamfetamine dimesylate capsules 60 mg by Solco Healthcare US, LLC. The label includes a blue and white design with 'Rx only' and displays 100 capsules per container. Storage instructions and manufacturer details (Prinston Laboratories) are also visible, along with a barcode.*
70 (Image 16)
Label for Lisdexamfetamine dimesylate capsules, 70 mg strength, showing a blue and gold design. It includes the prescription status (Rx only), the quantity of 100 capsules, and storage instructions. The label identifies Solco Healthcare US, LLC as the distributor and Prinlston Laboratories as the manufacturer. A barcode is visible on the right side.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
